0001493152-22-017528.txt : 20220622
0001493152-22-017528.hdr.sgml : 20220622
20220622171624
ACCESSION NUMBER: 0001493152-22-017528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220622
DATE AS OF CHANGE: 20220622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Holley Danica
CENTRAL INDEX KEY: 0001657320
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52218
FILM NUMBER: 221032904
BUSINESS ADDRESS:
BUSINESS PHONE: 2402045378
MAIL ADDRESS:
STREET 1: 4800 MONTGOMERY LANE SUITE 450
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERALINK TECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001362703
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202590810
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8000 INNOVATION PARK
STREET 2: DR, BATON ROUGE
CITY: BATON ROUGE
STATE: LA
ZIP: 70820
BUSINESS PHONE: 225-578-7555
MAIL ADDRESS:
STREET 1: 8000 INNOVATION PARK
STREET 2: DR, BATON ROUGE
CITY: BATON ROUGE
STATE: LA
ZIP: 70820
FORMER COMPANY:
FORMER CONFORMED NAME: OncBioMune Pharmaceuticals, Inc
DATE OF NAME CHANGE: 20150903
FORMER COMPANY:
FORMER CONFORMED NAME: QUINT MEDIA INC.
DATE OF NAME CHANGE: 20130807
FORMER COMPANY:
FORMER CONFORMED NAME: PediatRx Inc.
DATE OF NAME CHANGE: 20101230
4
1
ownership.xml
X0306
4
2022-06-15
0
0001362703
THERALINK TECHNOLOGIES, INC.
THER
0001657320
Holley Danica
9410 BILTMORE DRIVE
SILVER SPRING
MD
20901
1
0
0
0
8% Convertible Promissory Note
0.0048
2022-06-15
4
J
0
50000
50000
A
2022-06-29
2027-06-01
Common Stock
10504202
50000
D
Warrants (right to buy)
0.0048
2022-06-15
4
J
0
2100840
0
A
2022-06-15
2027-06-01
Common Stock
2100840
2100840
D
The Reporting Person purchased this promissory note from the corporation.
The promissory note may be converted at the Reporting Person's election at any time following amendment to the corporation's articles of incorporation with the Secretary of State of the State of Nevada to increase the corporation's authorized stock to 100,000,000,000. This amendment to the corporation's articles of incorporation is expected to be filed on June 29, 2022. Additionally, the promissory note will automatically convert upon the listing or trading of common stock on a qualified national exchange.
Excludes shares issuable at the election of the Reporting Person upon conversion of accrued interest (both past and future) into shares of common stock.
Granted to the Reporting Person as warrant coverage in connection with the convertible promissory note reported on this Table II.
/s/ Danica Holley
2022-06-22